EarlyDiagnostics
PrivateLast Round
Grant
Sep 1, 2023
Total Funding Raised
$3.99M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
EarlyDiagnostics operates in Healthcare & Life Sciences and is based in Agoura Hills, California. Its latest recorded funding round was a Grant round in September 2023.
EarlyDiagnostics is a healthcare technology company that provides accurate, affordable, and non-invasive liquid biopsy tests for early cancer detection and precision medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EarlyDiagnostics Comparables
Compare EarlyDiagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acuamark Diagnostics | 83% | |
| GenoME Diagnostics Ltd | 83% | |
| Adela | 81% |
For institutional investors. Book with your work email.
EarlyDiagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2023 | ||||
| Grant | Sep 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
EarlyDiagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Alpha Edison | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 2, 4x the trailing average.
- Jul 26, 2026
Monthly visitors increased 57% MoM.
For institutional investors. Book with your work email.
EarlyDiagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EarlyDiagnostics's valuation, stock price, and market status.
Is EarlyDiagnostics a public or private company?
EarlyDiagnostics is a private company.
What is the current stock price of EarlyDiagnostics?
EarlyDiagnostics is a private company, so its shares have no public market price. Caplight tracks EarlyDiagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EarlyDiagnostics worth (valuation)?
Valuation information for EarlyDiagnostics is not publicly available.
Can I buy EarlyDiagnostics stock?
EarlyDiagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EarlyDiagnostics's last funding round?
EarlyDiagnostics's most recent funding round was Grant on September 1, 2023.
Who are the main investors in EarlyDiagnostics?
Key investors in EarlyDiagnostics include NIH RADx, Alpha Edison.
Will EarlyDiagnostics IPO soon?
No public IPO plans have been announced for EarlyDiagnostics.
How can I track EarlyDiagnostics secondary market activity?
Caplight tracks bids, offers, and trades in EarlyDiagnostics's shares on secondary markets.